Insight Molecular Diagnostics Inc.
IMDX
$3.41
$0.041.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.74M | -6.67M | -33.51M | -13.49M | -4.53M |
| Total Depreciation and Amortization | 559.00K | 491.00K | 563.00K | 340.00K | 326.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.38M | 1.37M | 28.75M | 7.60M | -595.00K |
| Change in Net Operating Assets | -478.00K | -1.04M | -1.16M | -2.00K | -1.18M |
| Cash from Operations | -6.28M | -5.86M | -5.35M | -5.55M | -5.98M |
| Capital Expenditure | -349.00K | -307.00K | -214.00K | -87.00K | -191.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 4.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -349.00K | -307.00K | -210.00K | -87.00K | -191.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -114.00K | -98.00K | -82.00K | -86.00K | -33.00K |
| Issuance of Common Stock | 0.00 | 29.14M | 11.99M | 18.00K | 15.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | 0.00 | 0.00 | -5.39M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -487.00K | -1.07M | -187.00K | -538.00K |
| Cash from Financing | -114.00K | 28.56M | 10.84M | -255.00K | 9.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.74M | 22.39M | 5.27M | -5.89M | 3.68M |